Finally, we transfected AKT1 into ovarian cancer cells with or without 6RK73 treatment and found that AKT1 overexpression reactivated AKT1/Sp1/c-Myc signaling and reversed 6RK73-induced growth suppression. The gene discussed is MYC; the disease is ovarian carcinoma.